Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
Australia
Emertitus Research Sydney, Botany, New South Wales Emeritus Research Camberwell, Camberwell, Victoria Linear, Joondalup, Western Australia Linear, Nedlands, Western Australia New Zealand
PCRN Waikato, Nawton, Hamilton, Auckland Pacific Clinical Research Network-Auckland, Takapuna, Auckland PCRN Wellington, Ebdentown, Upper Hutt, Auckland